Friday 6 November 2026
Export AORT’s income statement to Excel — free account
Artivion, Inc.
AORT Healthcare Medical Devices
Artivion, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $441.3 million, up 13.6% from fiscal 2024.
- Revenue
- +9.17%
- EPS
- −214.3%
- Free cash flow
- −202.5%
- Total debt
- +68.2%
Quarter to September 2026, against a year earlier
20.38
4.95
−19.54%
Follow AORT
Alert me
Artivion, Inc. (AORT) P/E ratio
Artivion, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 1,741× (May 2019) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 217× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 584× | — |
| FY2018 | 0.0× | — |
| FY2017 | 174× | 201.58% |
| FY2016 | 57.6× | (25.23%) |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 0.0× | — |
| Jun 2026 | 0.0× | — |
| Mar 2026 | 146× | (32.56%) |
| Dec 2025 | 217× | — |
| 43 more quarters | Free account |
Against its own ten years
Low 0.0×
High 1,741×
Ten-year median
0.0×
Current reading's percentile
58
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| AORT Artivion, Inc. | n/m |
| LMRI Lumexa Imaging Holdings, Inc. compare | n/m |
| SIBN SiBone compare | n/m |
| ENOV Enovis Corporation compare | n/m |
| TNDM Tandem Diabetes Care, Inc. compare | n/m |
| ATEC Alphatec Holdings, Inc. compare | n/m |
| PRCT PROCEPT BioRobotics Corporation compare | n/m |
| IRMD iRadimed Corporation compare | 44.9× |
| IART Integra LifeSciences Holdings Corporation compare | 83.0× |
| Medical Devices industry median | 25.6× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)